Biomarker (normal range) | All patients mean/median (range), number | PE patients mean/median (range), number | Multiple myeloma mean/median (range), number | Breast cancer mean/median (range), number | Kidney cancer mean/median (range), number | Lung cancer mean/median (range), number | P-value |
---|---|---|---|---|---|---|---|
PT (70–130%) | 85/84 (16–133), n = 96 | 87.4/87.0 (47–115), n = 10 | 83/87 (39–106), n = 11 | 92/91 (62–133), n = 25 | 77/78 (16–131), n = 23 | 88.5/93.0 (32.0–121.0), n = 13 | ns |
APTT (28–37 s) | 33/32 (24–46), n = 89 | 31.4/30.5 (25–46), n = 10 | 29.9/29.0 (25–35), n = 11 | 30.1/29.0 (24–39), n = 25 | 35/35 (27–46), n = 19 | 34/32 (28–46), n = 19 | Myeloma: 0.046 Breast ca: 0.001 Kidney ca: 0.033 |
Thrombin time (17–25 s) | 18/16 (14–140), n = 86 | 17/16 (15–21), n = 11 | 29.3/16.5 (15–140), n = 10 | 17/16 (14–23), n = 25 | 16/16 (14–19), n = 18 | 16/16 (15–18), n = 11 | ns |
Fibrinogen (2–4 g/l) | 5.5/5.5 (0.5–10.1), n = 87 | 6.1/6.2 (4–8), n = 10 | 4.6–5.0 (0.7–6.8), n = 11 | 4.8/4.4 (2.3–8.0), n = 25 | 6.4/6.5 (3.4–9.8), n = 18 | 5.8/5.8 (4.0–7.1), n = 11 | Myeloma: 0.043 Breast ca: 0.013 Kidney ca: 0.025 |
Antithrombin (85–125%) | 99/98 (39–270), n = 85 | 120/111 (77–270), n = 10 | 98/100 (86–116), n = 9 | 100.6/102.5 (66–140) | 100/99 (81–121), n = 18 | 96/92 (79–124), n = 11 | ns |
D-dimer (< 0.5 mg/l) | 2.7/2.3 (0.2–6.9), n = 88 | 2.9/3.0 (1–5), n = 11 | 2.4–2.1 (0.2–5.0), n = 11 | 2.9/2.3 (0.5–5.7), n = 25 | 2.0/2.1 (0.3–5.0), n = 18 | 3.0/2.5 (1.4–5.0), n = 11 | ns |
FVIII (60–160 IU/dl) | 250/223 (61–544), n = 62 | 295/270 (195–457), n = 7 | 258/287 (86–366), n = 7 | 240/226 (107–544), n = 16 | 239/213 (159–425), n = 13 | 243/214 (178–374), n = 9 | ns |
Leuc (3.4–8.2 E9/l) | 8.1/7.6 (1.1–22.2), n = 100 | 9.6/9.6 (5.7–14.9), n = 2 | 6.9/6.3 (3.1–12.4), n = 11 | 7.3/7.6 (3.0–12.9), n = 27 | 8.2/8.0 (3.1–15.1), n = 23 | 11.2/10.1 (5.8–18.2), n = 13 | Lung ca: 0.000 |
Hgb (134–167 g/l) | 113/113 (64–151), n = 100 | 116/118 (89–150), n = 12 | 106/101 (64–150), n = 11 | 120/123 (98–142), n = 27 | 109/105 (78–144), n = 23 | 114/113 (87–139), n = 13 | Breast ca: 0.014 |
PLT 150–360 E9/l) | 267/267 (46–636), n = 100 | 275/292 (80–499), n = 12 | 201/159 (80–402), n = 11 | 238.9/243.0 (46–414), n = 27 | 301/286 (123–636), n = 23 | 280/290 (169–414), n = 13 | Myeloma: 0.022 |
Crea (60–100 umol/l) | 86/68 (32–776), n = 99 | 84/78 (46–181), n = 12 | 120/85 (58–361), n = 11 | 61/61 (32–112), n = 27 | 127/89 (50–776), n = 23 | 72/61 (41–159), n = 13 | Myeloma: 0.033 Breast ca: 0.003 Kidney ca: 0.000 |